tiprankstipranks
Trending News
More News >
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
US Market
Advertisement

Cannara Biotech (LOVFF) Income Statement

Compare
12 Followers

Cannara Biotech Income Statement

Last quarter (Q4 2025), Cannara Biotech's total revenue was C$28.63M, an increase of 24.30% from the same quarter last year. In Q4, Cannara Biotech's net income was C$3.31M. See Cannara Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 25Dec 24Dec 23Dec 22
Total Revenue
C$ 107.32MC$ ―C$ 81.75MC$ 57.26MC$ 35.84M
Gross Profit
C$ 47.22MC$ ―C$ 29.79MC$ 27.23MC$ 17.33M
Operating Expenses
C$ 25.02MC$ ―C$ 19.71MC$ 15.34MC$ 12.36M
Depreciation and Amortization
C$ 6.40MC$ ―C$ 6.35MC$ 4.94MC$ 3.92M
EBITDA
C$ 28.18MC$ ―C$ 15.16MC$ 15.77MC$ 9.54M
Operating Income
C$ 22.20MC$ ―C$ 10.08MC$ 11.89MC$ 3.67M
Other Income/Expenses
C$ -4.10MC$ ―C$ -5.59MC$ -4.94MC$ -2.64M
Pretax Income
C$ 18.10MC$ ―C$ 4.48MC$ 6.95MC$ 2.31M
Net Income
C$ 13.08MC$ ―C$ 6.44MC$ 6.95MC$ 2.31M
Per Share Metrics
Basic EPS
C$ 0.14C$ ―C$ 0.07C$ 0.08C$ 0.03
Diluted EPS
C$ 0.14C$ ―C$ 0.07C$ 0.08C$ 0.03
Weighted Average Shares Outstanding
93.40M 90.07M 89.30M 87.67M
Weighted Average Shares Outstanding (Diluted)
92.37M 91.39M 89.30M 87.84M
Currency in CAD

Cannara Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis